Ligand validation:5T6B

SAH: S-ADENOSYL-L-HOMOCYSTEINE

SAH is a Ligand Of Interest in 5T6B designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
5T6B_SAH_C_502	87%	18%	0.088	0.96	1.46	2.02	5	10	0	0	100%	1
5T6B_SAH_D_502	86%	23%	0.085	0.954	1.25	1.92	2	8	0	0	100%	1
5T6B_SAH_B_502	77%	15%	0.112	0.951	1.12	2.57	2	9	1	0	100%	1
5T6B_SAH_A_502	69%	17%	0.129	0.944	1.07	2.46	2	8	2	0	100%	1
5T64_SAH_B_502	95%	29%	0.068	0.972	1.15	1.66	3	5	0	0	100%	1
5T67_SAH_A_502	89%	17%	0.101	0.98	1.22	2.33	3	9	1	0	100%	1
2OB2_SAH_A_1801	100%	22%	0.023	0.994	1.25	1.94	3	4	0	0	100%	1
3LGA_SAH_B_301	100%	22%	0.027	0.994	1.32	1.89	2	3	0	0	100%	1
4QPP_SAH_A_1000	100%	37%	0.025	0.995	0.99	1.46	2	4	0	0	100%	1
8TDR_SAH_B_1001	100%	25%	0.029	0.996	1.26	1.79	3	4	0	0	100%	1
6I73_SAH_A_401	100%	49%	0.028	0.992	0.78	1.16	-	2	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.